Study to Identify Molecular Mechanisms of Clinical Resistance to Chemotherapy in Triple Negative Breast Cancer Patients

This study is currently recruiting participants.
Verified November 2012 by Jewish General Hospital
Sponsor:
Collaborators:
Quebec Clinical Research Organization in Cancer
Genome Quebec
Information provided by (Responsible Party):
Mark Basik, Jewish General Hospital
ClinicalTrials.gov Identifier:
NCT01276899
First received: January 12, 2011
Last updated: November 28, 2012
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given